Axogen director granted 4,392 RSUs valued at $185K

Weiler Kathy Johnson reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Weiler Kathy Johnson reported acquisition or exercise transactions in this Form 4 filing.

Axogen, Inc. director Kathy Johnson Weiler received a grant of 4,392 restricted stock units as annual equity compensation for her service on the board. Each unit represents a contingent right to receive one share of Axogen common stock. The grant is valued at $185,000 as of the grant date and will vest on June 24, 2027, the one-year anniversary of the grant date. Following this award, she holds 4,392 restricted stock units directly.

Insider Trade Summary

Grant/Award: 4,392 shares

Grant/Award 1 txn

Insider Weiler Kathy Johnson

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	4,392	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 4,392 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
2. F2. Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.

Key Figures

RSU grant size: 4,392 units Grant valuation: $185,000 Underlying common shares: 4,392 shares +2 more

5 metrics

RSU grant size 4,392 units Annual equity grant to director on grant date

Grant valuation $185,000 Valuation used to determine RSU count as of grant date

Underlying common shares 4,392 shares Each RSU represents one share of Axogen common stock

Holdings after grant 4,392 RSUs Total restricted stock units following transaction

Vesting date June 24, 2027 One-year anniversary of the grant date when RSUs vest

Key Terms

Restricted Stock Units, contingent right, Annual equity grant, vests

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of Axogen, Inc. common stock"

Annual equity grant financial

"Annual equity grant for service as Director on the Axogen, Inc. Board"

vests financial

"and vests on June 24, 2027, the one-year anniversary of the grant date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Axogen (AXGN) report for Kathy Johnson Weiler?

Axogen reported that director Kathy Johnson Weiler received 4,392 restricted stock units as an annual equity grant. The award is compensation for her service on the board and is structured as a derivative right to receive common shares in the future.

How many Axogen (AXGN) restricted stock units were granted in this Form 4?

The Form 4 shows a grant of 4,392 restricted stock units to director Kathy Johnson Weiler. Each unit represents a contingent right to receive one share of Axogen common stock if and when the award vests according to its stated schedule.

What is the dollar value of the Axogen (AXGN) RSU grant to Kathy Johnson Weiler?

The RSU grant is based on a $185,000 valuation as of the grant date. That valuation determines the number of restricted stock units awarded, aligning director compensation with the company’s share price at the time of the grant.

When do Kathy Johnson Weiler’s Axogen (AXGN) restricted stock units vest?

The restricted stock units vest on June 24, 2027, the one-year anniversary of the grant date. Vesting means the contingent right converts into actual shares of Axogen common stock, subject to the standard terms and conditions of the equity award.

What does each Axogen (AXGN) restricted stock unit represent in this filing?

Each restricted stock unit represents a contingent right to receive one share of Axogen common stock. The units do not deliver shares immediately; instead, shares are issued only upon vesting according to the award’s specified schedule and conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:52 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weiler Kathy Johnson

(Last) (First) (Middle)

C/O AXOGEN, INC. 13631 PROGRESS BLVD.,

SUITE 400

(Street)

ALACHUA FLORIDA 32615

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Axogen, Inc. [ AXGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/24/2026		A		4,392		(2)	(2)	Common Stock	4,392	$0	4,392	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

2. Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.

Remarks:

	/s/ Marc Began, as attorney-in-fact for Kathy Weiler	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)